AXB-33702-65108
3 vaccinations
9 coded responses
35 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 980 / WA
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Moderna
- 2021-01-15
-
2021-01-17
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Myalgia — Feeling: Good · Site: Pain · Joint pains, Muscle or body achesFree text: Attribute joint pains and muscle aches away from injection site to intense skate skiing 24 hours agoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-19
- 2021-01-22
- 2021-01-29
- 2021-02-05
-
2021-02-09
Dose 2 — Moderna
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Fatigue or tiredness, Diarrhea, Abdominal painAdult check-in
- 2021-02-13
- 2021-02-14
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-17
- 2021-03-23
- 2021-05-11
-
2021-08-10
Survey response — 6 months, dose 2MedDRA: Impaired work ability, Respiratory tract infection, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: I had a respiratory infection in July but my COVID test came back negative. I did not attend work one day, however this was not due to symptom severity, but because Im a healthcare worker and we ask that we do not come in if symptomatic.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-23
Dose 3 — Moderna
-
2021-10-23
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain, Decreased appetite — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Chest pain, decrease in appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Brain fog — Feeling: Fair · Site: Pain, Swelling, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: FogginessMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-28
- 2021-10-29
-
2021-11-08
Survey response — day 14, dose 3MedDRA: Anaphylactic reaction, Emergency care, Urticaria — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had an anaphylactic reaction without a known trigger 5days ago that required observation in the ED and that was treated effectively with Benadryl, did not require epinephrine. I did need a dose of dexamethasone 2days ago for ongoing sx (hives).MedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Survey response — day 21, dose 3MedDRA: Emergency care, Hypersensitivity, Self-medication, Urticaria — Feeling: FairFree text: Continuing to have hives, which first appeared during allergic reaction on 11/3 (ED visit). Treating symptomatically with Benadryl per ED discharge.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-20
- 2021-11-27
- 2021-12-06
-
2022-01-22
Survey response — 3 months, dose 3MedDRA: Mast cell activation syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: I appear to have had something that looks like a mast cell-like reaction, which began in November and has been diminishingly present since then. I'm taking daily antihistamines per my physician and we'll reassess my plan in the next few weeks.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-22
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2022-01-25
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-23
Survey response — 6 months, dose 3MedDRA: Office visit, Pre-existing disease, Self-medication, Urticaria — Feeling: GoodFree text: My previous symptoms were diagnosed by my immunologist as chronic urticaria and I'm taking high-dose Zyrtec to treat it. The symptoms have not worsened but new triggers seem to trigger the episodes. The severity has gone down over time.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Survey response — 12 months, dose 3MedDRA: Postural orthostatic tachycardia syndrome — Feeling: Good · Be unable to do your normal daily activitiesFree text: POTS (clinical diagnosis, tilt table test upcoming)MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-09 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Attribute joint pains and muscle aches away from injection site to intense skate skiing 24 hours ago
Release 9 — 6 months, dose 2
Symptoms: I had a respiratory infection in July but my COVID test came back negative. I did not attend work one day, however this was not due to symptom severity, but because Im a healthcare worker and we ask that we do not come in if symptomatic.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Chest pain, decrease in appetite
Systemic reaction (other): Fogginess
Release 10 — day 14, dose 3
Symptoms: I had an anaphylactic reaction without a known trigger 5days ago that required observation in the ED and that was treated effectively with Benadryl, did not require epinephrine. I did need a dose of dexamethasone 2days ago for ongoing sx (hives).
Release 10 — day 21, dose 3
Symptoms: Continuing to have hives, which first appeared during allergic reaction on 11/3 (ED visit). Treating symptomatically with Benadryl per ED discharge.
Release 11 — 3 months, dose 3
Symptoms: I appear to have had something that looks like a mast cell-like reaction, which began in November and has been diminishingly present since then. I'm taking daily antihistamines per my physician and we'll reassess my plan in the next few weeks.
Release 11 — 6 months, dose 3
Symptoms: My previous symptoms were diagnosed by my immunologist as chronic urticaria and I'm taking high-dose Zyrtec to treat it. The symptoms have not worsened but new triggers seem to trigger the episodes. The severity has gone down over time.
Release 12 — 12 months, dose 3
Symptoms: POTS (clinical diagnosis, tilt table test upcoming)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anaphylactic reaction | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Impaired work ability | ✓ | · | ✓ |
| SD | Mast cell activation syndrome | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Postural orthostatic tachycardia syndrome | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract infection | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release